Jeannie M. Padowski
Jeannie M. Padowski
Clinical Associate Professor
Department of Pharmacology and Toxicology
Jacobs School of Medicine & Biomedical Sciences
Education and Training:
- Fellowship, Senior Fellow, University of Washington (2012)
- PhD, Toxicology, University of North Carolina at Chapel Hill (2008)
- BA, Brain and Cognitive Sciences; Psychology, University of Rochester (2001)
Employment:
- Clinical Associate Professor, Pharmacology and Toxicology, University at Buffalo | Jacobs School of Medicine and Biomedical Sciences (2021-present)
- Clinical Associate Professor, University of Toledo | College of Pharmacy and Pharmaceutical Sciences; College of Medicine and Life Sciences (2019–2021)
- Clinical Associate Professor, Washington State University | College of Pharmacy and Pharmaceutical Sciences; Elson S Floyd College of Medicine (2012–2019)
Awards and Honors:
- Pharmacy Teacher of the Year (selected by first year students) (2019)
- Outstanding Contribution to Curriculum Development & Educational Scholarship (2018)
- Pharmacy Teacher of the Year (selected by first year students) (2018)
Journal Articles:
- Gufford BT, Ainslie GR, White JR, Layton ME, Padowski JM, Pollack GM, Paine MF. (2017) Comparison of a New Intranasal Naloxone Formulation to Intramuscular Naloxone: Results from Hypothesis-generating Small Clinical Studies. Clinical and translational science (Sep), 10(5): 380-386. doi:10.1111/cts.12473
- Mischley LK, Lau RC, Shankland EG, Wilbur TK, Padowski JM. (2017) Phase IIb Study of Intranasal Glutathione in Parkinson's Disease. Journal of Parkinson's disease (Jan), 7(2): 289-299. doi:10.3233/JPD-161040
- Mischley LK, Conley KE, Shankland EG, Kavanagh TJ, Rosenfeld ME, Duda JE, White CC, Wilbur TK, De La Torre PU, Padowski JM. (2016) Central nervous system uptake of intranasal glutathione in Parkinson's disease. NPJ Parkinson's disease (Jan), 2: 16002. doi:10.1038/npjparkd.2016.2
- White JR, Padowski JM, Zhong Y, Chen G, Luo S, Lazarus P, Layton ME, McPherson S. (2016) Pharmacokinetic analysis and comparison of caffeine administered rapidly or slowly in coffee chilled or hot versus chilled energy drink in healthy young adults. Clinical toxicology (Philadelphia, Pa.) (Jan), 54(4): 308-12. doi:10.3109/15563650.2016.1146740
- Padowski JM, Weaver KE, Richards TL, Laurino MY, Samii A, Aylward EH, Conley KE. (2014) Neurochemical correlates of caudate atrophy in Huntington's disease. Movement disorders : official journal of the Movement Disorder Society (Mar), 29(3): 327-35. doi:10.1002/mds.25801
- Padowski JM, Pollack GM. (2012) Influence of enterohepatic recycling on the time course of brain-to-blood partitioning of valproic acid in rats. Drug metabolism and disposition: the biological fate of chemicals (Sep), 40(9): 1846-53. doi:10.1124/dmd.112.045500
- Padowski JM, Pollack GM. (2011) Influence of time to achieve substrate distribution equilibrium between brain tissue and blood on quantitation of the blood-brain barrier P-glycoprotein effect. Brain research (Dec), 1426: 1-17.
- Padowski JM, Pollack GM. (2011) The influence of distributional kinetics into a peripheral compartment on the pharmacokinetics of substrate partitioning between blood and brain tissue. Journal of pharmacokinetics and pharmacodynamics (Dec), 38(6): 743-67.
- Padowski JM, Pollack GM. (2010) Examination of the ability of the nasal administration route to confer a brain exposure advantage for three chemical inhibitors of P-glycoprotein. Journal of pharmaceutical sciences (Jul), 99(7): 3226-33.
- Padowski JM, Pollack GM. (2010) Pharmacokinetic and pharmacodynamic implications of P-glycoprotein modulation. Methods in molecular biology (Clifton, N.J.) (Jan), 596: 359-84.
- Joseph SA, Lynd-Balta E, O'Banion MK, Rappold PM, Daschner J, Allen A, Padowski J. (2006) Enhanced cyclooxygenase-2 expression in olfactory-limbic forebrain following kainate-induced seizures. Neuroscience (Jul), 140(3): 1051-65.
- Korones DN, Padowski J, Factor BA, Constine LS. (2003) Do children with optic pathway tumors have an increased frequency of other central nervous system tumors?. Neuro-oncology (Apr), 5(2): 116-20. doi:10.1215/S1522-8517-02-00030-3
- Mischley LK, Standish LJ, Weiss NS, Padowski JM, Kavanagh TJ, White CC, Rosenfeld ME. (1900) Glutathione as a Biomarker in Parkinson's Disease: Associations with Aging and Disease Severity. Oxidative medicine and cellular longevity (Jan), 2016: 9409363. doi:10.1155/2016/9409363
Professional Memberships:
- American Association of Pharmaceutical Scientists